Support for psychedelic research continues to gain acceptance at the federal level as the National Institute on Drug Abuse (NIDA) announces a funding grant for research proposals of psychedelic medicine.
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) https://t.co/kr3xqmsJGM
— NIH Funding (@NIHFunding) May 16, 2023
Under the Department of Health and Human Services and the National Institutes of Health (NIH), three notices of funding opportunities were published this week, calling for submissions of research projects focused on how psychedelics could be used for substance use disorders (SUDs).
The government agencies are seeking proposals and research initiatives into the treatment of drug addiction using psychedelics, with an allocated $1.5 million in funding.
Click here for a complete look at the announcement and call for submission.
For more on federal support for psychedelics, see Bipartisan Group Pushes Congress for Psychedelic Research
The post U.S. Government Announces $1.5 Million Grant For Psychedelics Research appeared first on Microdose.psychedelics psychedelic funding research
Law & Regulation3 days ago
Psilocybin study for bipolar depression encourages more research
LSD4 days ago
TECH HEAVY: The Magnificent Seven has suddenly become the Fantastic Four
Psilocybin3 days ago
Magic Mushroom Edibles: Everything to Know, from Chocolates to Drops
Ketamine3 days ago
Prepping the psychedelic industry for MDMA approval
Psychedelics3 days ago
Psychedelics Effects on Sexual Functions
Law & Regulation2 days ago
Enveric sells cannabis patents to focus on psilocin candidates